HomeSwitzerland

Switzerland

C.En Completes Financing Round with Generali Group

C.En Ltd., a Zurich, Switzerland-based developer of hydrogen storage technology, has completed a round of equity financing.The round was led by Generali Financial Holdings...

Cardiola Raises Additional $4M in Series E Financing Round

Cardiola AG, a Winterthur-Switzerland-based company that develops a device for treating chronic heart failure, announced today that it has raised an additional $4m...

Swiss Xigen Completed €20M Series B Financing Round

Xigen SA, a Swiss biopharmaceutical company, with a focus on inflammation, announced the completion earlier this year of a €20m (CHF 20m) Series B...

capiton Closes its Private Equity Fund caption IV on €350m

capiton AG, a Berlin, Germany-based independent private equity firm, announced the final closing of its capiton IV fund.According to the company, the targeted fund...

Argos Soditic Acquires Majority Stake in Swiss Misapor

Argos Soditic, an independent European private equity firm with offices in Geneva, Paris and Milan, acquired, through an MBO, a majority stake in MISAPOR,...

Swiss Biocartis Raises €10M in Series A Financing Round

Biocartis SA closed its €10m ($14.9m) Series A equity financing round led by Amsterdam-based Aescap Venture with participation from a syndicate of European investors...

South Europe, Investindustrial Closes Fund III Build-up Fund at €100M Target

Investindustrial, Southern Europe’s leading private equity firm, completed the raising of its Build-Up Fund for the €500m Investindustrial III L.P. ('Fund III') at the...

Evolva Agrees to Go Public Via Merger with Arpida

Evolva, a Swiss biotech company, agreed to go public via a reverse merger with Arpida, which is listed on the Swiss stock exchange.The Basel-based...

Swiss Endosense Closes US$ 36m Series B Financing

Endosense, a Swiss medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, announced...

Swiss Genesis Invest applies for admittance to the Entry Standard

Genesis Invest AG announced its decision to apply for admittance to the Entry Standard, the Deutsche Börse segment within the Open Market that provides...

THE DAILY NEWSLETTER - SIGNUP